Single amino acid substitutions in the AR ligand binding pocket such as T877A or H874Y, which change the ligand specificities of the AR, have been reported in patients with castration-resistant metastatic prostate cancer [8,9]. Here, AR is linked to metastatic prostate carcinoma.